The gut microbiome is unique to each person and has a major impact on health. Orally administered probiotics are used to prevent and/or treat gastrointestinal (GI) disorders and additionally show potential in the treatment of non-GI conditions. In vitro studies lead to a better understanding of the biological properties of therapeutically used microorganisms and the positive effects they can have ...
Magnez (Mg) odgrywa kluczową rolę w podtrzymywaniu prawidłowego funkcjonowania organizmu, w związku z czym jego niedobór wiąże się z różnymi chorobami przewlekłymi. Diagnoza niedoboru Mg jest trudna ze względu na brak specyficznych objawów i jego wpływ na zdrowie. Podnoszenie świadomości pracowników systemu opieki zdrowotnej może ułatwić dokładną diagnozę i odpowiednie leczenie. W niniejszym ...
A recent study based on the National Health and Wellness Survey, the world’s largest online database of patient-reported health outcomes, found that low vitality negatively impacts quality of life, daily activities and productivity. While dietary supplement solutions exist to prevent fatigue, the study also showed that people disengaged in self-managing their health have the lowest vitality level.
Clinical trial demonstrating non-inferiority of Poliprotect for heartburn and epigastric pain in patients without erosive esophagitis
A randomised, controlled, multicentre, double-blind and double-masked study confirmed the efficacy of Poliprotect®, a molecular complex of natural ingredients designed for the protection of the gastroesophageal mucosa, contained in the medicinal product NeoBianacid®. Poliprotect was non-inferior to the standard dose of omeprazole (20 mg/day) in the treatment of symptoms of non-erosive gastroe ...
Musculoskeletal (MSK) disorders are the leading cause of chronic pain, physical, functional impairment and loss of quality of life. About one in three people worldwide is suffering from MSK pain. The biological effects of bioceramic materials as Infrared-C emitters on body tissues and their benefits to the self-management of MSK disorders, are the subject of current interest.
Autor: Bill Giannakopoulos, PharmD, Mohamed Amessou, PhD, MBA i Eva Koscova, MD, PhD, MBA, CVTI SREFSM: 2023;3:230049DOI: 10.52778/efsm.23.0049Data: 17.12.2023
Oral antihistamines are first-line treatments for children with allergic rhinitis. A recent review evaluated second-generation antihistamines in comparison to first-generation antihistamines.